nodes	percent_of_prediction	percent_of_DWPC	metapath
Lansoprazole—Blood potassium increased—Ramipril—type 1 diabetes mellitus	0.0325	0.0421	CcSEcCtD
Lansoprazole—Transient ischaemic attack—Ramipril—type 1 diabetes mellitus	0.0195	0.0252	CcSEcCtD
Lansoprazole—Parosmia—Ramipril—type 1 diabetes mellitus	0.0151	0.0196	CcSEcCtD
Lansoprazole—Ageusia—Ramipril—type 1 diabetes mellitus	0.0121	0.0157	CcSEcCtD
Lansoprazole—Endocrine disorder—Ramipril—type 1 diabetes mellitus	0.0119	0.0153	CcSEcCtD
Lansoprazole—Cough increased—Ramipril—type 1 diabetes mellitus	0.0107	0.0139	CcSEcCtD
Lansoprazole—Glossitis—Ramipril—type 1 diabetes mellitus	0.0107	0.0138	CcSEcCtD
Lansoprazole—Creatinine increased—Ramipril—type 1 diabetes mellitus	0.0103	0.0134	CcSEcCtD
Lansoprazole—Salivary hypersecretion—Ramipril—type 1 diabetes mellitus	0.00954	0.0124	CcSEcCtD
Lansoprazole—Blood urea increased—Ramipril—type 1 diabetes mellitus	0.00928	0.012	CcSEcCtD
Lansoprazole—Neuropathy—Ramipril—type 1 diabetes mellitus	0.00923	0.0119	CcSEcCtD
Lansoprazole—Rash maculo-papular—Ramipril—type 1 diabetes mellitus	0.00893	0.0116	CcSEcCtD
Lansoprazole—Urine output increased—Ramipril—type 1 diabetes mellitus	0.00888	0.0115	CcSEcCtD
Lansoprazole—Gynaecomastia—Ramipril—type 1 diabetes mellitus	0.00879	0.0114	CcSEcCtD
Lansoprazole—Sleep disorder—Ramipril—type 1 diabetes mellitus	0.00824	0.0107	CcSEcCtD
Lansoprazole—Photosensitivity—Ramipril—type 1 diabetes mellitus	0.00812	0.0105	CcSEcCtD
Lansoprazole—Polyuria—Ramipril—type 1 diabetes mellitus	0.00812	0.0105	CcSEcCtD
Lansoprazole—Gastroenteritis—Ramipril—type 1 diabetes mellitus	0.00805	0.0104	CcSEcCtD
Lansoprazole—Deafness—Ramipril—type 1 diabetes mellitus	0.00797	0.0103	CcSEcCtD
Lansoprazole—Vascular purpura—Ramipril—type 1 diabetes mellitus	0.00797	0.0103	CcSEcCtD
Lansoprazole—Haemolytic anaemia—Ramipril—type 1 diabetes mellitus	0.0079	0.0102	CcSEcCtD
Lansoprazole—Renal failure acute—Ramipril—type 1 diabetes mellitus	0.00773	0.01	CcSEcCtD
Lansoprazole—Libido decreased—Ramipril—type 1 diabetes mellitus	0.00769	0.00996	CcSEcCtD
Lansoprazole—Amnesia—Ramipril—type 1 diabetes mellitus	0.00759	0.00983	CcSEcCtD
Lansoprazole—Dermatitis exfoliative—Ramipril—type 1 diabetes mellitus	0.00756	0.00978	CcSEcCtD
Lansoprazole—Renal impairment—Ramipril—type 1 diabetes mellitus	0.00749	0.0097	CcSEcCtD
Lansoprazole—Purpura—Ramipril—type 1 diabetes mellitus	0.0074	0.00958	CcSEcCtD
Lansoprazole—Anaphylactoid reaction—Ramipril—type 1 diabetes mellitus	0.00737	0.00954	CcSEcCtD
Lansoprazole—Arthritis—Ramipril—type 1 diabetes mellitus	0.00734	0.0095	CcSEcCtD
Lansoprazole—Hypoglycaemia—Ramipril—type 1 diabetes mellitus	0.00731	0.00946	CcSEcCtD
Lansoprazole—Cerebrovascular accident—Ramipril—type 1 diabetes mellitus	0.00728	0.00942	CcSEcCtD
Lansoprazole—Hyponatraemia—Ramipril—type 1 diabetes mellitus	0.00716	0.00927	CcSEcCtD
Lansoprazole—Disturbance in sexual arousal—Ramipril—type 1 diabetes mellitus	0.00708	0.00916	CcSEcCtD
Lansoprazole—Blood creatinine increased—Ramipril—type 1 diabetes mellitus	0.00668	0.00865	CcSEcCtD
Lansoprazole—Liver function test abnormal—Ramipril—type 1 diabetes mellitus	0.00659	0.00852	CcSEcCtD
Lansoprazole—Breast disorder—Ramipril—type 1 diabetes mellitus	0.00645	0.00834	CcSEcCtD
Lansoprazole—Cramp muscle—Ramipril—type 1 diabetes mellitus	0.00642	0.00831	CcSEcCtD
Lansoprazole—Toxic epidermal necrolysis—Ramipril—type 1 diabetes mellitus	0.00642	0.00831	CcSEcCtD
Lansoprazole—Gastritis—Ramipril—type 1 diabetes mellitus	0.00631	0.00817	CcSEcCtD
Lansoprazole—Asthma—Ramipril—type 1 diabetes mellitus	0.00616	0.00798	CcSEcCtD
Lansoprazole—Dysphagia—Ramipril—type 1 diabetes mellitus	0.00616	0.00798	CcSEcCtD
Lansoprazole—Influenza—Ramipril—type 1 diabetes mellitus	0.00616	0.00798	CcSEcCtD
Lansoprazole—Eosinophilia—Ramipril—type 1 diabetes mellitus	0.0061	0.0079	CcSEcCtD
Lansoprazole—Pancreatitis—Ramipril—type 1 diabetes mellitus	0.00604	0.00782	CcSEcCtD
Lansoprazole—Angina pectoris—Ramipril—type 1 diabetes mellitus	0.00601	0.00777	CcSEcCtD
Lansoprazole—Bronchitis—Ramipril—type 1 diabetes mellitus	0.00593	0.00767	CcSEcCtD
Lansoprazole—Abdominal discomfort—Ramipril—type 1 diabetes mellitus	0.00591	0.00765	CcSEcCtD
Lansoprazole—Pancytopenia—Ramipril—type 1 diabetes mellitus	0.00585	0.00758	CcSEcCtD
Lansoprazole—Neutropenia—Ramipril—type 1 diabetes mellitus	0.00576	0.00746	CcSEcCtD
Lansoprazole—Upper respiratory tract infection—Ramipril—type 1 diabetes mellitus	0.00573	0.00742	CcSEcCtD
Lansoprazole—Erectile dysfunction—Ramipril—type 1 diabetes mellitus	0.00568	0.00735	CcSEcCtD
Lansoprazole—Photosensitivity reaction—Ramipril—type 1 diabetes mellitus	0.00563	0.00728	CcSEcCtD
Lansoprazole—Weight increased—Ramipril—type 1 diabetes mellitus	0.00561	0.00726	CcSEcCtD
Lansoprazole—Stevens-Johnson syndrome—Ramipril—type 1 diabetes mellitus	0.00545	0.00705	CcSEcCtD
Lansoprazole—Acute coronary syndrome—Ramipril—type 1 diabetes mellitus	0.00542	0.00701	CcSEcCtD
Lansoprazole—Renal failure—Ramipril—type 1 diabetes mellitus	0.0054	0.00699	CcSEcCtD
Lansoprazole—Neuropathy peripheral—Ramipril—type 1 diabetes mellitus	0.00539	0.00697	CcSEcCtD
Lansoprazole—Myocardial infarction—Ramipril—type 1 diabetes mellitus	0.00539	0.00697	CcSEcCtD
Lansoprazole—Jaundice—Ramipril—type 1 diabetes mellitus	0.00536	0.00693	CcSEcCtD
Lansoprazole—Stomatitis—Ramipril—type 1 diabetes mellitus	0.00536	0.00693	CcSEcCtD
Lansoprazole—Conjunctivitis—Ramipril—type 1 diabetes mellitus	0.00534	0.00692	CcSEcCtD
Lansoprazole—Urinary tract infection—Ramipril—type 1 diabetes mellitus	0.00534	0.00692	CcSEcCtD
Lansoprazole—Sweating—Ramipril—type 1 diabetes mellitus	0.00527	0.00682	CcSEcCtD
Lansoprazole—Hepatobiliary disease—Ramipril—type 1 diabetes mellitus	0.0052	0.00673	CcSEcCtD
Lansoprazole—Epistaxis—Ramipril—type 1 diabetes mellitus	0.00518	0.00671	CcSEcCtD
Lansoprazole—Sinusitis—Ramipril—type 1 diabetes mellitus	0.00516	0.00667	CcSEcCtD
Lansoprazole—Agranulocytosis—Ramipril—type 1 diabetes mellitus	0.00513	0.00664	CcSEcCtD
Lansoprazole—Hepatitis—Ramipril—type 1 diabetes mellitus	0.00493	0.00639	CcSEcCtD
Lansoprazole—Oedema peripheral—Ramipril—type 1 diabetes mellitus	0.00486	0.00629	CcSEcCtD
Lansoprazole—Connective tissue disorder—Ramipril—type 1 diabetes mellitus	0.00485	0.00628	CcSEcCtD
Lansoprazole—Visual impairment—Ramipril—type 1 diabetes mellitus	0.00476	0.00615	CcSEcCtD
Lansoprazole—Erythema multiforme—Ramipril—type 1 diabetes mellitus	0.00467	0.00604	CcSEcCtD
Lansoprazole—Tinnitus—Ramipril—type 1 diabetes mellitus	0.0046	0.00595	CcSEcCtD
Lansoprazole—Immune system disorder—Ramipril—type 1 diabetes mellitus	0.00446	0.00577	CcSEcCtD
Lansoprazole—Mediastinal disorder—Ramipril—type 1 diabetes mellitus	0.00445	0.00576	CcSEcCtD
Lansoprazole—Arrhythmia—Ramipril—type 1 diabetes mellitus	0.00441	0.00571	CcSEcCtD
Lansoprazole—Alopecia—Ramipril—type 1 diabetes mellitus	0.00436	0.00564	CcSEcCtD
Lansoprazole—Mental disorder—Ramipril—type 1 diabetes mellitus	0.00432	0.0056	CcSEcCtD
Lansoprazole—Erythema—Ramipril—type 1 diabetes mellitus	0.0043	0.00556	CcSEcCtD
Lansoprazole—Malnutrition—Ramipril—type 1 diabetes mellitus	0.0043	0.00556	CcSEcCtD
Lansoprazole—Tension—Ramipril—type 1 diabetes mellitus	0.00422	0.00546	CcSEcCtD
Lansoprazole—Dysgeusia—Ramipril—type 1 diabetes mellitus	0.00421	0.00544	CcSEcCtD
Lansoprazole—Nervousness—Ramipril—type 1 diabetes mellitus	0.00417	0.0054	CcSEcCtD
Lansoprazole—Muscle spasms—Ramipril—type 1 diabetes mellitus	0.00413	0.00535	CcSEcCtD
Lansoprazole—Tremor—Ramipril—type 1 diabetes mellitus	0.00402	0.00521	CcSEcCtD
Lansoprazole—Ill-defined disorder—Ramipril—type 1 diabetes mellitus	0.00399	0.00516	CcSEcCtD
Lansoprazole—Agitation—Ramipril—type 1 diabetes mellitus	0.00395	0.00511	CcSEcCtD
Lansoprazole—Angioedema—Ramipril—type 1 diabetes mellitus	0.00392	0.00508	CcSEcCtD
Lansoprazole—Malaise—Ramipril—type 1 diabetes mellitus	0.00387	0.00501	CcSEcCtD
Lansoprazole—Vertigo—Ramipril—type 1 diabetes mellitus	0.00386	0.00499	CcSEcCtD
Lansoprazole—Syncope—Ramipril—type 1 diabetes mellitus	0.00385	0.00499	CcSEcCtD
Lansoprazole—Leukopenia—Ramipril—type 1 diabetes mellitus	0.00384	0.00498	CcSEcCtD
Lansoprazole—Palpitations—Ramipril—type 1 diabetes mellitus	0.0038	0.00491	CcSEcCtD
Lansoprazole—Loss of consciousness—Ramipril—type 1 diabetes mellitus	0.00378	0.00489	CcSEcCtD
Lansoprazole—Cough—Ramipril—type 1 diabetes mellitus	0.00375	0.00485	CcSEcCtD
Lansoprazole—Convulsion—Ramipril—type 1 diabetes mellitus	0.00372	0.00482	CcSEcCtD
Lansoprazole—Myalgia—Ramipril—type 1 diabetes mellitus	0.00366	0.00473	CcSEcCtD
Lansoprazole—Arthralgia—Ramipril—type 1 diabetes mellitus	0.00366	0.00473	CcSEcCtD
Lansoprazole—Chest pain—Ramipril—type 1 diabetes mellitus	0.00366	0.00473	CcSEcCtD
Lansoprazole—Anxiety—Ramipril—type 1 diabetes mellitus	0.00364	0.00472	CcSEcCtD
Lansoprazole—Unspecified disorder of skin and subcutaneous tissue—Ramipril—type 1 diabetes mellitus	0.00363	0.0047	CcSEcCtD
Lansoprazole—Discomfort—Ramipril—type 1 diabetes mellitus	0.00361	0.00468	CcSEcCtD
Lansoprazole—Dry mouth—Ramipril—type 1 diabetes mellitus	0.00358	0.00463	CcSEcCtD
Lansoprazole—Confusional state—Ramipril—type 1 diabetes mellitus	0.00353	0.00458	CcSEcCtD
Lansoprazole—Oedema—Ramipril—type 1 diabetes mellitus	0.00351	0.00454	CcSEcCtD
Lansoprazole—Anaphylactic shock—Ramipril—type 1 diabetes mellitus	0.00351	0.00454	CcSEcCtD
Lansoprazole—Shock—Ramipril—type 1 diabetes mellitus	0.00345	0.00446	CcSEcCtD
Lansoprazole—Nervous system disorder—Ramipril—type 1 diabetes mellitus	0.00344	0.00445	CcSEcCtD
Lansoprazole—Thrombocytopenia—Ramipril—type 1 diabetes mellitus	0.00343	0.00444	CcSEcCtD
Lansoprazole—Tachycardia—Ramipril—type 1 diabetes mellitus	0.00342	0.00443	CcSEcCtD
Lansoprazole—Skin disorder—Ramipril—type 1 diabetes mellitus	0.00341	0.00441	CcSEcCtD
Lansoprazole—Hyperhidrosis—Ramipril—type 1 diabetes mellitus	0.00339	0.00439	CcSEcCtD
Lansoprazole—Anorexia—Ramipril—type 1 diabetes mellitus	0.00334	0.00433	CcSEcCtD
Lansoprazole—Hypotension—Ramipril—type 1 diabetes mellitus	0.00328	0.00424	CcSEcCtD
Lansoprazole—Musculoskeletal discomfort—Ramipril—type 1 diabetes mellitus	0.00319	0.00413	CcSEcCtD
Lansoprazole—Insomnia—Ramipril—type 1 diabetes mellitus	0.00317	0.0041	CcSEcCtD
Lansoprazole—Paraesthesia—Ramipril—type 1 diabetes mellitus	0.00315	0.00407	CcSEcCtD
Lansoprazole—Dyspnoea—Ramipril—type 1 diabetes mellitus	0.00313	0.00405	CcSEcCtD
Lansoprazole—Somnolence—Ramipril—type 1 diabetes mellitus	0.00312	0.00403	CcSEcCtD
Lansoprazole—Dyspepsia—Ramipril—type 1 diabetes mellitus	0.00309	0.00399	CcSEcCtD
Lansoprazole—Decreased appetite—Ramipril—type 1 diabetes mellitus	0.00305	0.00394	CcSEcCtD
Lansoprazole—Gastrointestinal disorder—Ramipril—type 1 diabetes mellitus	0.00303	0.00392	CcSEcCtD
Lansoprazole—Fatigue—Ramipril—type 1 diabetes mellitus	0.00302	0.00391	CcSEcCtD
Lansoprazole—Constipation—Ramipril—type 1 diabetes mellitus	0.003	0.00388	CcSEcCtD
Lansoprazole—Feeling abnormal—Ramipril—type 1 diabetes mellitus	0.00289	0.00374	CcSEcCtD
Lansoprazole—Gastrointestinal pain—Ramipril—type 1 diabetes mellitus	0.00287	0.00371	CcSEcCtD
Lansoprazole—Urticaria—Ramipril—type 1 diabetes mellitus	0.00278	0.0036	CcSEcCtD
Lansoprazole—Abdominal pain—Ramipril—type 1 diabetes mellitus	0.00277	0.00359	CcSEcCtD
Lansoprazole—Body temperature increased—Ramipril—type 1 diabetes mellitus	0.00277	0.00359	CcSEcCtD
Lansoprazole—Hypersensitivity—Ramipril—type 1 diabetes mellitus	0.00258	0.00334	CcSEcCtD
Lansoprazole—Asthenia—Ramipril—type 1 diabetes mellitus	0.00252	0.00326	CcSEcCtD
Lansoprazole—Pruritus—Ramipril—type 1 diabetes mellitus	0.00248	0.00321	CcSEcCtD
Lansoprazole—Diarrhoea—Ramipril—type 1 diabetes mellitus	0.0024	0.0031	CcSEcCtD
Lansoprazole—Dizziness—Ramipril—type 1 diabetes mellitus	0.00232	0.003	CcSEcCtD
Lansoprazole—Vomiting—Ramipril—type 1 diabetes mellitus	0.00223	0.00288	CcSEcCtD
Lansoprazole—Rash—Ramipril—type 1 diabetes mellitus	0.00221	0.00286	CcSEcCtD
Lansoprazole—Dermatitis—Ramipril—type 1 diabetes mellitus	0.00221	0.00286	CcSEcCtD
Lansoprazole—Headache—Ramipril—type 1 diabetes mellitus	0.0022	0.00284	CcSEcCtD
Lansoprazole—Nausea—Ramipril—type 1 diabetes mellitus	0.00208	0.0027	CcSEcCtD
Lansoprazole—ABCB1—Allograft Rejection—HLA-DPB1—type 1 diabetes mellitus	0.000585	0.00257	CbGpPWpGaD
Lansoprazole—ABCB1—Allograft Rejection—HLA-E—type 1 diabetes mellitus	0.000575	0.00253	CbGpPWpGaD
Lansoprazole—CYP1A2—Tryptophan metabolism—CAT—type 1 diabetes mellitus	0.000562	0.00247	CbGpPWpGaD
Lansoprazole—ABCB1—Allograft Rejection—CTLA4—type 1 diabetes mellitus	0.000554	0.00244	CbGpPWpGaD
Lansoprazole—CYP1B1—Aryl Hydrocarbon Receptor—EGFR—type 1 diabetes mellitus	0.00054	0.00237	CbGpPWpGaD
Lansoprazole—CYP1B1—Aryl Hydrocarbon Receptor Pathway—EGFR—type 1 diabetes mellitus	0.00054	0.00237	CbGpPWpGaD
Lansoprazole—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—type 1 diabetes mellitus	0.000536	0.00236	CbGpPWpGaD
Lansoprazole—MAPT—Apoptosis—TNF—type 1 diabetes mellitus	0.000521	0.00229	CbGpPWpGaD
Lansoprazole—CYP1B1—Aryl Hydrocarbon Receptor Pathway—TNF—type 1 diabetes mellitus	0.000514	0.00226	CbGpPWpGaD
Lansoprazole—CYP1B1—Aryl Hydrocarbon Receptor—TNF—type 1 diabetes mellitus	0.000514	0.00226	CbGpPWpGaD
Lansoprazole—MAPT—MAPK Signaling Pathway—EGFR—type 1 diabetes mellitus	0.000513	0.00226	CbGpPWpGaD
Lansoprazole—CYP1A2—Aryl Hydrocarbon Receptor—E2F1—type 1 diabetes mellitus	0.000513	0.00226	CbGpPWpGaD
Lansoprazole—CYP1A2—Phase II conjugation—GSTT1—type 1 diabetes mellitus	0.000496	0.00218	CbGpPWpGaD
Lansoprazole—CYP1A1—Aryl Hydrocarbon Receptor Pathway—IFNG—type 1 diabetes mellitus	0.000489	0.00215	CbGpPWpGaD
Lansoprazole—MAPT—MAPK Signaling Pathway—TNF—type 1 diabetes mellitus	0.000489	0.00215	CbGpPWpGaD
Lansoprazole—ABCB1—Allograft Rejection—HLA-DQA1—type 1 diabetes mellitus	0.000488	0.00215	CbGpPWpGaD
Lansoprazole—ATP4B—Transmembrane transport of small molecules—ALB—type 1 diabetes mellitus	0.000484	0.00213	CbGpPWpGaD
Lansoprazole—MAPT—Integrated Pancreatic Cancer Pathway—EGFR—type 1 diabetes mellitus	0.000463	0.00204	CbGpPWpGaD
Lansoprazole—ABCG2—Transmembrane transport of small molecules—G6PC2—type 1 diabetes mellitus	0.000462	0.00203	CbGpPWpGaD
Lansoprazole—ABCB1—Allograft Rejection—HLA-DQB1—type 1 diabetes mellitus	0.000456	0.00201	CbGpPWpGaD
Lansoprazole—CYP1A1—Biological oxidations—GSTT1—type 1 diabetes mellitus	0.000455	0.002	CbGpPWpGaD
Lansoprazole—ABCB1—Integrated Pancreatic Cancer Pathway—IL1R1—type 1 diabetes mellitus	0.000452	0.00199	CbGpPWpGaD
Lansoprazole—CYP4A11—Metabolism of lipids and lipoproteins—APOC3—type 1 diabetes mellitus	0.000448	0.00197	CbGpPWpGaD
Lansoprazole—MAPT—Integrated Pancreatic Cancer Pathway—TNF—type 1 diabetes mellitus	0.000441	0.00194	CbGpPWpGaD
Lansoprazole—ABCB1—Allograft Rejection—CD86—type 1 diabetes mellitus	0.00044	0.00193	CbGpPWpGaD
Lansoprazole—CYP1A1—Aryl Hydrocarbon Receptor Pathway—IL1B—type 1 diabetes mellitus	0.000436	0.00192	CbGpPWpGaD
Lansoprazole—CYP1A1—Aryl Hydrocarbon Receptor Pathway—IL2—type 1 diabetes mellitus	0.000435	0.00191	CbGpPWpGaD
Lansoprazole—CYP3A4—Tryptophan metabolism—CAT—type 1 diabetes mellitus	0.000433	0.00191	CbGpPWpGaD
Lansoprazole—ATP4A—Transmembrane transport of small molecules—ALB—type 1 diabetes mellitus	0.000431	0.0019	CbGpPWpGaD
Lansoprazole—ABCB1—Allograft Rejection—IL10—type 1 diabetes mellitus	0.000431	0.0019	CbGpPWpGaD
Lansoprazole—ABCB1—Allograft Rejection—CD40LG—type 1 diabetes mellitus	0.000431	0.0019	CbGpPWpGaD
Lansoprazole—ABCB1—Allograft Rejection—IL4—type 1 diabetes mellitus	0.000419	0.00184	CbGpPWpGaD
Lansoprazole—CYP2C8—Biological oxidations—GSTT1—type 1 diabetes mellitus	0.000417	0.00183	CbGpPWpGaD
Lansoprazole—ABCB1—Transmembrane transport of small molecules—SLC29A3—type 1 diabetes mellitus	0.000412	0.00181	CbGpPWpGaD
Lansoprazole—ABCB1—Allograft Rejection—HLA-B—type 1 diabetes mellitus	0.00041	0.0018	CbGpPWpGaD
Lansoprazole—ABCB1—Allograft Rejection—FASLG—type 1 diabetes mellitus	0.000401	0.00176	CbGpPWpGaD
Lansoprazole—ABCG2—Transmembrane transport of small molecules—ABCC8—type 1 diabetes mellitus	0.0004	0.00176	CbGpPWpGaD
Lansoprazole—CYP4A11—Metabolism—HBA2—type 1 diabetes mellitus	0.000392	0.00172	CbGpPWpGaD
Lansoprazole—ABCB1—Allograft Rejection—IL2RA—type 1 diabetes mellitus	0.000384	0.00169	CbGpPWpGaD
Lansoprazole—ABCB1—HIF-1-alpha transcription factor network—NOS2—type 1 diabetes mellitus	0.000382	0.00168	CbGpPWpGaD
Lansoprazole—ABCB1—Allograft Rejection—HLA-A—type 1 diabetes mellitus	0.00038	0.00167	CbGpPWpGaD
Lansoprazole—CYP2C19—Biological oxidations—GSTT1—type 1 diabetes mellitus	0.000372	0.00164	CbGpPWpGaD
Lansoprazole—CYP4A11—Metabolism—G6PC2—type 1 diabetes mellitus	0.000369	0.00162	CbGpPWpGaD
Lansoprazole—ABCB1—Allograft Rejection—HLA-DRB1—type 1 diabetes mellitus	0.000347	0.00153	CbGpPWpGaD
Lansoprazole—CYP2C18—Metabolism—HBA2—type 1 diabetes mellitus	0.000343	0.00151	CbGpPWpGaD
Lansoprazole—CYP2D6—Biological oxidations—GSTT1—type 1 diabetes mellitus	0.000342	0.00151	CbGpPWpGaD
Lansoprazole—ABCB1—Integrated Pancreatic Cancer Pathway—IAPP—type 1 diabetes mellitus	0.00034	0.0015	CbGpPWpGaD
Lansoprazole—CYP2C9—Biological oxidations—GSTT1—type 1 diabetes mellitus	0.000339	0.00149	CbGpPWpGaD
Lansoprazole—CYP1A1—Aryl Hydrocarbon Receptor Pathway—EGFR—type 1 diabetes mellitus	0.000332	0.00146	CbGpPWpGaD
Lansoprazole—CYP1A1—Aryl Hydrocarbon Receptor—EGFR—type 1 diabetes mellitus	0.000332	0.00146	CbGpPWpGaD
Lansoprazole—CYP2C18—Metabolism—G6PC2—type 1 diabetes mellitus	0.000322	0.00142	CbGpPWpGaD
Lansoprazole—ABCB1—Allograft Rejection—CD80—type 1 diabetes mellitus	0.000321	0.00141	CbGpPWpGaD
Lansoprazole—CYP4A11—Metabolism—ABCC8—type 1 diabetes mellitus	0.00032	0.00141	CbGpPWpGaD
Lansoprazole—CYP1A1—Aryl Hydrocarbon Receptor—TNF—type 1 diabetes mellitus	0.000317	0.00139	CbGpPWpGaD
Lansoprazole—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TNF—type 1 diabetes mellitus	0.000317	0.00139	CbGpPWpGaD
Lansoprazole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—type 1 diabetes mellitus	0.000312	0.00137	CbGpPWpGaD
Lansoprazole—ABCG2—Transmembrane transport of small molecules—SLC18A2—type 1 diabetes mellitus	0.000306	0.00135	CbGpPWpGaD
Lansoprazole—CYP1A2—Biological oxidations—GSTT1—type 1 diabetes mellitus	0.00029	0.00128	CbGpPWpGaD
Lansoprazole—CYP1B1—Metabolism of lipids and lipoproteins—APOC3—type 1 diabetes mellitus	0.000289	0.00127	CbGpPWpGaD
Lansoprazole—ABCG2—Transmembrane transport of small molecules—CP—type 1 diabetes mellitus	0.000282	0.00124	CbGpPWpGaD
Lansoprazole—ABCG2—Transmembrane transport of small molecules—SLC11A1—type 1 diabetes mellitus	0.00028	0.00123	CbGpPWpGaD
Lansoprazole—CYP2C18—Metabolism—ABCC8—type 1 diabetes mellitus	0.000279	0.00123	CbGpPWpGaD
Lansoprazole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—type 1 diabetes mellitus	0.000278	0.00122	CbGpPWpGaD
Lansoprazole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—type 1 diabetes mellitus	0.000277	0.00122	CbGpPWpGaD
Lansoprazole—ABCB1—Allograft Rejection—IFNG—type 1 diabetes mellitus	0.000253	0.00111	CbGpPWpGaD
Lansoprazole—CYP4A11—Metabolism—KCNJ11—type 1 diabetes mellitus	0.000253	0.00111	CbGpPWpGaD
Lansoprazole—CYP1B1—Metabolism—HBA2—type 1 diabetes mellitus	0.000253	0.00111	CbGpPWpGaD
Lansoprazole—ABCB1—Transmembrane transport of small molecules—G6PC2—type 1 diabetes mellitus	0.00025	0.0011	CbGpPWpGaD
Lansoprazole—CYP1B1—Metabolism—G6PC2—type 1 diabetes mellitus	0.000238	0.00104	CbGpPWpGaD
Lansoprazole—ABCG2—Metabolism—HBA2—type 1 diabetes mellitus	0.00023	0.00101	CbGpPWpGaD
Lansoprazole—ABCB1—Allograft Rejection—IL1B—type 1 diabetes mellitus	0.000226	0.000994	CbGpPWpGaD
Lansoprazole—ABCB1—Allograft Rejection—CASP3—type 1 diabetes mellitus	0.000226	0.000992	CbGpPWpGaD
Lansoprazole—ABCB1—Allograft Rejection—IL2—type 1 diabetes mellitus	0.000225	0.000991	CbGpPWpGaD
Lansoprazole—CYP3A4—Biological oxidations—GSTT1—type 1 diabetes mellitus	0.000224	0.000984	CbGpPWpGaD
Lansoprazole—CYP2C18—Metabolism—KCNJ11—type 1 diabetes mellitus	0.000221	0.000971	CbGpPWpGaD
Lansoprazole—ABCB1—Transmembrane transport of small molecules—ABCC8—type 1 diabetes mellitus	0.000216	0.000952	CbGpPWpGaD
Lansoprazole—ABCG2—Metabolism—G6PC2—type 1 diabetes mellitus	0.000216	0.000951	CbGpPWpGaD
Lansoprazole—CYP4A11—Metabolism—ITPR3—type 1 diabetes mellitus	0.000213	0.000938	CbGpPWpGaD
Lansoprazole—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—type 1 diabetes mellitus	0.000212	0.000932	CbGpPWpGaD
Lansoprazole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—type 1 diabetes mellitus	0.000212	0.000932	CbGpPWpGaD
Lansoprazole—CYP1B1—Metabolism—ABCC8—type 1 diabetes mellitus	0.000206	0.000906	CbGpPWpGaD
Lansoprazole—ABCB1—Integrated Pancreatic Cancer Pathway—E2F1—type 1 diabetes mellitus	0.000206	0.000905	CbGpPWpGaD
Lansoprazole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—type 1 diabetes mellitus	0.000202	0.000888	CbGpPWpGaD
Lansoprazole—CYP1A2—Aryl Hydrocarbon Receptor—TNF—type 1 diabetes mellitus	0.000202	0.000888	CbGpPWpGaD
Lansoprazole—CYP4A11—Metabolism—HBA1—type 1 diabetes mellitus	0.000201	0.000883	CbGpPWpGaD
Lansoprazole—CYP4A11—Metabolism—APOC3—type 1 diabetes mellitus	0.0002	0.000877	CbGpPWpGaD
Lansoprazole—ABCB1—Integrated Pancreatic Cancer Pathway—FASLG—type 1 diabetes mellitus	0.000198	0.00087	CbGpPWpGaD
Lansoprazole—CYP4A11—Metabolism—GSTT1—type 1 diabetes mellitus	0.000196	0.000862	CbGpPWpGaD
Lansoprazole—ABCG2—Metabolism—ABCC8—type 1 diabetes mellitus	0.000187	0.000824	CbGpPWpGaD
Lansoprazole—CYP2C18—Metabolism—ITPR3—type 1 diabetes mellitus	0.000186	0.00082	CbGpPWpGaD
Lansoprazole—CYP4A11—Metabolism of lipids and lipoproteins—ALB—type 1 diabetes mellitus	0.000181	0.000794	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism of lipids and lipoproteins—APOC3—type 1 diabetes mellitus	0.000178	0.000782	CbGpPWpGaD
Lansoprazole—CYP2C18—Metabolism—HBA1—type 1 diabetes mellitus	0.000175	0.000772	CbGpPWpGaD
Lansoprazole—CYP2C18—Metabolism—APOC3—type 1 diabetes mellitus	0.000174	0.000767	CbGpPWpGaD
Lansoprazole—CYP2C18—Metabolism—GSTT1—type 1 diabetes mellitus	0.000171	0.000753	CbGpPWpGaD
Lansoprazole—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—type 1 diabetes mellitus	0.000168	0.000738	CbGpPWpGaD
Lansoprazole—ABCB1—Transmembrane transport of small molecules—SLC18A2—type 1 diabetes mellitus	0.000166	0.000728	CbGpPWpGaD
Lansoprazole—ABCB1—Allograft Rejection—TNF—type 1 diabetes mellitus	0.000164	0.000722	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism of lipids and lipoproteins—APOC3—type 1 diabetes mellitus	0.000163	0.000717	CbGpPWpGaD
Lansoprazole—CYP1B1—Metabolism—KCNJ11—type 1 diabetes mellitus	0.000163	0.000716	CbGpPWpGaD
Lansoprazole—CYP4A11—Metabolism—GCG—type 1 diabetes mellitus	0.000156	0.000687	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—HBA2—type 1 diabetes mellitus	0.000156	0.000684	CbGpPWpGaD
Lansoprazole—ABCB1—Transmembrane transport of small molecules—CP—type 1 diabetes mellitus	0.000152	0.00067	CbGpPWpGaD
Lansoprazole—ABCB1—Transmembrane transport of small molecules—SLC11A1—type 1 diabetes mellitus	0.000151	0.000665	CbGpPWpGaD
Lansoprazole—ABCG2—Metabolism—KCNJ11—type 1 diabetes mellitus	0.000148	0.000652	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—G6PC2—type 1 diabetes mellitus	0.000146	0.000644	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism of lipids and lipoproteins—APOC3—type 1 diabetes mellitus	0.000145	0.00064	CbGpPWpGaD
Lansoprazole—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—type 1 diabetes mellitus	0.000145	0.000636	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—HBA2—type 1 diabetes mellitus	0.000143	0.000628	CbGpPWpGaD
Lansoprazole—CYP1B1—Metabolism—ITPR3—type 1 diabetes mellitus	0.000137	0.000605	CbGpPWpGaD
Lansoprazole—CYP2C18—Metabolism—GCG—type 1 diabetes mellitus	0.000136	0.0006	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—G6PC2—type 1 diabetes mellitus	0.000134	0.00059	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism of lipids and lipoproteins—APOC3—type 1 diabetes mellitus	0.000133	0.000583	CbGpPWpGaD
Lansoprazole—CYP4A11—Metabolism—CAT—type 1 diabetes mellitus	0.000132	0.000581	CbGpPWpGaD
Lansoprazole—CYP1B1—Metabolism—HBA1—type 1 diabetes mellitus	0.000129	0.000569	CbGpPWpGaD
Lansoprazole—CYP1B1—Metabolism—APOC3—type 1 diabetes mellitus	0.000129	0.000565	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—HBA2—type 1 diabetes mellitus	0.000127	0.00056	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—ABCC8—type 1 diabetes mellitus	0.000127	0.000558	CbGpPWpGaD
Lansoprazole—CYP1B1—Metabolism—GSTT1—type 1 diabetes mellitus	0.000126	0.000555	CbGpPWpGaD
Lansoprazole—ABCG2—Metabolism—ITPR3—type 1 diabetes mellitus	0.000125	0.00055	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—HBA2—type 1 diabetes mellitus	0.000124	0.000547	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—G6PC2—type 1 diabetes mellitus	0.00012	0.000527	CbGpPWpGaD
Lansoprazole—ABCG2—Metabolism—HBA1—type 1 diabetes mellitus	0.000118	0.000518	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—HBA2—type 1 diabetes mellitus	0.000117	0.000515	CbGpPWpGaD
Lansoprazole—ABCG2—Metabolism—APOC3—type 1 diabetes mellitus	0.000117	0.000514	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—G6PC2—type 1 diabetes mellitus	0.000117	0.000514	CbGpPWpGaD
Lansoprazole—CYP1B1—Metabolism of lipids and lipoproteins—ALB—type 1 diabetes mellitus	0.000116	0.000512	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—ABCC8—type 1 diabetes mellitus	0.000116	0.000512	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—HBA2—type 1 diabetes mellitus	0.000116	0.000511	CbGpPWpGaD
Lansoprazole—CYP2C18—Metabolism—CAT—type 1 diabetes mellitus	0.000116	0.000508	CbGpPWpGaD
Lansoprazole—ABCG2—Metabolism—GSTT1—type 1 diabetes mellitus	0.000115	0.000505	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism of lipids and lipoproteins—APOC3—type 1 diabetes mellitus	0.000113	0.000499	CbGpPWpGaD
Lansoprazole—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—type 1 diabetes mellitus	0.000111	0.00049	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—G6PC2—type 1 diabetes mellitus	0.00011	0.000484	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—G6PC2—type 1 diabetes mellitus	0.000109	0.00048	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—ABCC8—type 1 diabetes mellitus	0.000104	0.000457	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—ABCC8—type 1 diabetes mellitus	0.000101	0.000446	CbGpPWpGaD
Lansoprazole—ABCG2—Transmembrane transport of small molecules—ALB—type 1 diabetes mellitus	0.000101	0.000443	CbGpPWpGaD
Lansoprazole—CYP1B1—Metabolism—GCG—type 1 diabetes mellitus	0.000101	0.000442	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—KCNJ11—type 1 diabetes mellitus	0.0001	0.000441	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—HBA2—type 1 diabetes mellitus	9.92e-05	0.000436	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—ABCC8—type 1 diabetes mellitus	9.55e-05	0.00042	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—ABCC8—type 1 diabetes mellitus	9.47e-05	0.000416	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—G6PC2—type 1 diabetes mellitus	9.33e-05	0.00041	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—KCNJ11—type 1 diabetes mellitus	9.19e-05	0.000404	CbGpPWpGaD
Lansoprazole—ABCG2—Metabolism—GCG—type 1 diabetes mellitus	9.15e-05	0.000403	CbGpPWpGaD
Lansoprazole—CYP4A11—Metabolism—INS—type 1 diabetes mellitus	8.77e-05	0.000386	CbGpPWpGaD
Lansoprazole—CYP1B1—Metabolism—CAT—type 1 diabetes mellitus	8.52e-05	0.000375	CbGpPWpGaD
Lansoprazole—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—type 1 diabetes mellitus	8.5e-05	0.000374	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—ITPR3—type 1 diabetes mellitus	8.47e-05	0.000372	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—KCNJ11—type 1 diabetes mellitus	8.21e-05	0.000361	CbGpPWpGaD
Lansoprazole—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—type 1 diabetes mellitus	8.1e-05	0.000356	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—ABCC8—type 1 diabetes mellitus	8.09e-05	0.000356	CbGpPWpGaD
Lansoprazole—CYP4A11—Metabolism—ALB—type 1 diabetes mellitus	8.04e-05	0.000354	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—KCNJ11—type 1 diabetes mellitus	8.01e-05	0.000352	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—HBA1—type 1 diabetes mellitus	7.97e-05	0.00035	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—APOC3—type 1 diabetes mellitus	7.92e-05	0.000348	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—GSTT1—type 1 diabetes mellitus	7.78e-05	0.000342	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—ITPR3—type 1 diabetes mellitus	7.76e-05	0.000341	CbGpPWpGaD
Lansoprazole—ABCG2—Metabolism—CAT—type 1 diabetes mellitus	7.75e-05	0.000341	CbGpPWpGaD
Lansoprazole—CYP4A11—Metabolism—NOS3—type 1 diabetes mellitus	7.69e-05	0.000338	CbGpPWpGaD
Lansoprazole—CYP2C18—Metabolism—INS—type 1 diabetes mellitus	7.67e-05	0.000337	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—HBA2—type 1 diabetes mellitus	7.66e-05	0.000337	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—KCNJ11—type 1 diabetes mellitus	7.55e-05	0.000332	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—KCNJ11—type 1 diabetes mellitus	7.48e-05	0.000329	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—HBA1—type 1 diabetes mellitus	7.3e-05	0.000321	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—APOC3—type 1 diabetes mellitus	7.26e-05	0.000319	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—G6PC2—type 1 diabetes mellitus	7.2e-05	0.000317	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism of lipids and lipoproteins—ALB—type 1 diabetes mellitus	7.17e-05	0.000315	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—GSTT1—type 1 diabetes mellitus	7.13e-05	0.000314	CbGpPWpGaD
Lansoprazole—CYP2C18—Metabolism—ALB—type 1 diabetes mellitus	7.03e-05	0.000309	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—ITPR3—type 1 diabetes mellitus	6.93e-05	0.000305	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—ITPR3—type 1 diabetes mellitus	6.76e-05	0.000297	CbGpPWpGaD
Lansoprazole—CYP2C18—Metabolism—NOS3—type 1 diabetes mellitus	6.72e-05	0.000296	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism of lipids and lipoproteins—ALB—type 1 diabetes mellitus	6.57e-05	0.000289	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—HBA1—type 1 diabetes mellitus	6.52e-05	0.000287	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—APOC3—type 1 diabetes mellitus	6.48e-05	0.000285	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—KCNJ11—type 1 diabetes mellitus	6.39e-05	0.000281	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—ITPR3—type 1 diabetes mellitus	6.37e-05	0.00028	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—HBA1—type 1 diabetes mellitus	6.36e-05	0.00028	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—GSTT1—type 1 diabetes mellitus	6.36e-05	0.00028	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—APOC3—type 1 diabetes mellitus	6.32e-05	0.000278	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—ITPR3—type 1 diabetes mellitus	6.32e-05	0.000278	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—ABCC8—type 1 diabetes mellitus	6.24e-05	0.000275	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—GSTT1—type 1 diabetes mellitus	6.21e-05	0.000273	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—GCG—type 1 diabetes mellitus	6.2e-05	0.000272	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—HBA1—type 1 diabetes mellitus	6e-05	0.000264	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—APOC3—type 1 diabetes mellitus	5.96e-05	0.000262	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—HBA1—type 1 diabetes mellitus	5.94e-05	0.000261	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—APOC3—type 1 diabetes mellitus	5.91e-05	0.00026	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism of lipids and lipoproteins—ALB—type 1 diabetes mellitus	5.86e-05	0.000258	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—GSTT1—type 1 diabetes mellitus	5.85e-05	0.000257	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—GSTT1—type 1 diabetes mellitus	5.8e-05	0.000255	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—GCG—type 1 diabetes mellitus	5.68e-05	0.00025	CbGpPWpGaD
Lansoprazole—CYP1B1—Metabolism—INS—type 1 diabetes mellitus	5.65e-05	0.000249	CbGpPWpGaD
Lansoprazole—ABCB1—Transmembrane transport of small molecules—ALB—type 1 diabetes mellitus	5.44e-05	0.000239	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—ITPR3—type 1 diabetes mellitus	5.4e-05	0.000237	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism of lipids and lipoproteins—ALB—type 1 diabetes mellitus	5.35e-05	0.000235	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—CAT—type 1 diabetes mellitus	5.25e-05	0.000231	CbGpPWpGaD
Lansoprazole—CYP1B1—Metabolism—ALB—type 1 diabetes mellitus	5.18e-05	0.000228	CbGpPWpGaD
Lansoprazole—ABCG2—Metabolism—INS—type 1 diabetes mellitus	5.14e-05	0.000226	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—HBA1—type 1 diabetes mellitus	5.08e-05	0.000223	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—GCG—type 1 diabetes mellitus	5.07e-05	0.000223	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—APOC3—type 1 diabetes mellitus	5.05e-05	0.000222	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—GSTT1—type 1 diabetes mellitus	4.96e-05	0.000218	CbGpPWpGaD
Lansoprazole—CYP1B1—Metabolism—NOS3—type 1 diabetes mellitus	4.96e-05	0.000218	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—GCG—type 1 diabetes mellitus	4.95e-05	0.000218	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—KCNJ11—type 1 diabetes mellitus	4.94e-05	0.000217	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—CAT—type 1 diabetes mellitus	4.81e-05	0.000211	CbGpPWpGaD
Lansoprazole—ABCG2—Metabolism—ALB—type 1 diabetes mellitus	4.72e-05	0.000207	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—GCG—type 1 diabetes mellitus	4.66e-05	0.000205	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—GCG—type 1 diabetes mellitus	4.62e-05	0.000203	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism of lipids and lipoproteins—ALB—type 1 diabetes mellitus	4.57e-05	0.000201	CbGpPWpGaD
Lansoprazole—ABCG2—Metabolism—NOS3—type 1 diabetes mellitus	4.51e-05	0.000198	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—CAT—type 1 diabetes mellitus	4.29e-05	0.000189	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—CAT—type 1 diabetes mellitus	4.19e-05	0.000184	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—ITPR3—type 1 diabetes mellitus	4.17e-05	0.000183	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—GCG—type 1 diabetes mellitus	3.95e-05	0.000174	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—CAT—type 1 diabetes mellitus	3.95e-05	0.000174	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—HBA1—type 1 diabetes mellitus	3.92e-05	0.000172	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—CAT—type 1 diabetes mellitus	3.91e-05	0.000172	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—APOC3—type 1 diabetes mellitus	3.9e-05	0.000171	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—GSTT1—type 1 diabetes mellitus	3.83e-05	0.000168	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—INS—type 1 diabetes mellitus	3.48e-05	0.000153	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—CAT—type 1 diabetes mellitus	3.34e-05	0.000147	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—INS—type 1 diabetes mellitus	3.19e-05	0.00014	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—ALB—type 1 diabetes mellitus	3.19e-05	0.00014	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—NOS3—type 1 diabetes mellitus	3.05e-05	0.000134	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—GCG—type 1 diabetes mellitus	3.05e-05	0.000134	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—ALB—type 1 diabetes mellitus	2.93e-05	0.000129	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—INS—type 1 diabetes mellitus	2.85e-05	0.000125	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—NOS3—type 1 diabetes mellitus	2.8e-05	0.000123	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—INS—type 1 diabetes mellitus	2.78e-05	0.000122	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—INS—type 1 diabetes mellitus	2.62e-05	0.000115	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—ALB—type 1 diabetes mellitus	2.61e-05	0.000115	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—INS—type 1 diabetes mellitus	2.6e-05	0.000114	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—CAT—type 1 diabetes mellitus	2.58e-05	0.000114	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—ALB—type 1 diabetes mellitus	2.55e-05	0.000112	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—NOS3—type 1 diabetes mellitus	2.5e-05	0.00011	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—NOS3—type 1 diabetes mellitus	2.44e-05	0.000107	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—ALB—type 1 diabetes mellitus	2.4e-05	0.000106	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—ALB—type 1 diabetes mellitus	2.38e-05	0.000105	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—NOS3—type 1 diabetes mellitus	2.3e-05	0.000101	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—NOS3—type 1 diabetes mellitus	2.28e-05	0.0001	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—INS—type 1 diabetes mellitus	2.22e-05	9.76e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—ALB—type 1 diabetes mellitus	2.04e-05	8.95e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—NOS3—type 1 diabetes mellitus	1.95e-05	8.56e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—INS—type 1 diabetes mellitus	1.71e-05	7.53e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—ALB—type 1 diabetes mellitus	1.57e-05	6.91e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—NOS3—type 1 diabetes mellitus	1.5e-05	6.61e-05	CbGpPWpGaD
